Bottiar

Bottiar is an oral medication containing Linagliptin, used to manage type 2 diabetes. It helps control blood sugar levels and is commonly prescribed as part of a diabetes management plan.

Bottiar is primarily used to improve glycemic control in adults with type 2 diabetes. It works by increasing the levels of insulin produced by the pancreas and decreasing the amount of sugar produced by the liver. This medication is often used in combination with diet and exercise to manage blood sugar levels effectively.

Common effects of Bottiar may include headache, dizziness, and upper respiratory tract infection. Some users might experience nausea or diarrhea. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Bottiar should be handled with care, especially by individuals with a history of kidney or liver problems. It is important to follow the prescribed dosage and not to exceed it unless directed by a healthcare provider. Always store the medication in a cool, dry place away from direct sunlight.

Bottiar may interact with certain medications, including other diabetes drugs, antibiotics, and antifungal agents. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.